Skip to main content

Table 2 Univariate analysis of disease-free survival and overall survival of patients with pure mucinous carcinoma

From: Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women

Ā 

Disease-free survival

Overall survival

Ā 

Hazard ratio

P

Hazard ratio

P

Age, years

>1

0.603

<1

0.329

Tumor size, cm

<1

0.717

>1

0.999

Grade, I vs II

NA

0.998

NA

NA

Lymphovascular invasion (present vs absent)

NA

0.998

NA

0.999

ER (positive vs negative)

<1

0.139

<1

0.997

PR (positive vs negative)

<1

0.580

<1

0.343

HER2 (positive vs negative)

>1

0.122

<1

0.998

Lymph node status (positive vs negative)

NA

0.997

NA

0.998

Primary treatment (mastectomy vs lumpectomy with RT)

<1

0.996

<1

0.997

Primary treatment (mastectomy vs lumpectomy without RT)

<1

0.997

<1

0.998

Systemic therapy (endocrine therapy alone vs with chemotherapy)

>1

0.746

NA

NA

  1. ER estrogen receptor, PR progesterone receptor, RT radiotherapy, NA not applicable.